{"version":"1.0","type":"link","title":"Novel combination of irreversible electroporation and allogenic chimeric antigen receptor (CAR) T-cell therapy synergizes therapeutic outcomes in a preclinical human pancreatic cancer mouse model.","author_name":"Jacobs E 외","author_url":"https://prs-insight.online/author/Jacobs%20E","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/152121","thumbnail_width":1200,"thumbnail_height":630}